- Home
- HIMX vs JAGX Comparison
HIMX vs JAGX Comparison
Compare HIMX & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMX
- JAGX
- Stock Information
- Founded
- HIMX 2001
- JAGX 2013
- Country
- HIMX Taiwan
- JAGX United States
- Employees
- HIMX N/A
- JAGX 49
- Industry
- HIMX Semiconductors
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- HIMX Technology
- JAGX Health Care
- Exchange
- HIMX Nasdaq
- JAGX Nasdaq
- Market Cap
- HIMX N/A
- JAGX 3.1M
- IPO Year
- HIMX 2006
- JAGX N/A
- Fundamental
- Price
- HIMX $7.44
- JAGX $4.85
- Analyst Decision
- HIMX Buy
- JAGX
- Analyst Count
- HIMX 1
- JAGX 0
- Target Price
- HIMX $15.00
- JAGX N/A
- AVG Volume (30 Days)
- HIMX 2.4M
- JAGX 37.8K
- Earning Date
- HIMX 05-08-2025
- JAGX 03-31-2025
- Dividend Yield
- HIMX 3.95%
- JAGX N/A
- EPS Growth
- HIMX 62.86
- JAGX N/A
- EPS
- HIMX 0.46
- JAGX N/A
- Revenue
- HIMX $906,802,000.00
- JAGX $11,689,000.00
- Revenue This Year
- HIMX $6.01
- JAGX $18.18
- Revenue Next Year
- HIMX $13.18
- JAGX $40.06
- P/E Ratio
- HIMX $16.12
- JAGX N/A
- Revenue Growth
- HIMX N/A
- JAGX 19.75
- 52 Week Low
- HIMX $4.80
- JAGX $4.41
- 52 Week High
- HIMX $13.91
- JAGX $540.00
- Technical
- Relative Strength Index (RSI)
- HIMX 35.37
- JAGX 20.48
- Support Level
- HIMX $8.37
- JAGX $4.41
- Resistance Level
- HIMX $8.76
- JAGX $5.45
- Average True Range (ATR)
- HIMX 0.39
- JAGX 0.95
- MACD
- HIMX -0.14
- JAGX 0.00
- Stochastic Oscillator
- HIMX 11.72
- JAGX 3.54
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.